In the News
Dr. Barbara Farrell gives an overview of CaDeN in the Ottawa Citizen, reviews some of the challenges with deprescribing and describes Dr. Cara Tannenbaum’s CIHR research on deprescribing conversations.
CaDeN executive members, Barbara Farrell and Jim Silvius were featured on CTV and CBC news in response to a Canadian Institute for Health Information (CIHI) report about the use of antipsychotics in long term care facilities.
The Bruyère Research Institute welcomes Dr. Emily Reeve, an Australian pharmacist with a research fellowship to develop deprescribing guidelines for people with dementia. Emily will work with Dr. Farrell’s research team to learn about their process for developing...
Over 100 health care professionals, patient advocates and health care organization representatives met in Toronto to discuss CaDeN’s action plan and to share resources and tools for deprescribing.
The PPI deprescribing guideline has been downloaded over 2000 times since its release in September, 2015. A corresponding patient pamphlet and translation policy is now available.